Ag cross-presentation enables the delivery of tumor-associated Ag (TAA) to the MHC I. Thus, efficient TAA cross-presentation by APC is a key requirement for the induction of an effective CD8+ T cell response against tumors. The gene discussed is CD8A; the disease is neoplasm.